Rehabilitation and activity program after donor stem cell transplant
Part of Blood & lymphatic clinical trials.
This study looks at whether a rehabilitation and exercise program can help people recover after an allogeneic stem cell transplant. It aims to improve your recovery and quality of life after the transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are scheduled to receive a stem cell transplant from a donor (allogeneic stem cell transplant).
- You are able to provide written informed consent to participate.
- You are 18 years old or older.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an adapted physical activity (tailored exercise) can help people recover after a donor stem cell transplant for blood cancers. If you’re able to participate, the program may support strength, well-being, and recovery during the transplant process.
This study looks at how well patients do after receiving a stem cell transplant from a donor (called an allogeneic transplant). It aims to better understand the long-term outcomes and help improve care for future patients.
This study looks at a personalized rehabilitation program for people who are eligible to receive a bone marrow transplant from a donor. The goal is to improve recovery and function after transplant.
This study tests whether a guided exercise program, done mostly online, helps adults recover more quickly after a stem cell transplant for a myeloid blood disorder. It looks at physical strength, daily functioning, and overall well-being during the transplant hospital stay and the weeks after.
This trial studies whether an exercise program (“prehab” before transplant and “rehab” after) can improve outcomes for people age 60+ getting an allogeneic stem cell transplant for blood cancer. It focuses on fitness and recovery, especially for those who are pre-frail or frail.
This study looks at heart problems that can happen after a stem cell transplant from a donor (allogeneic). It aims to understand these risks better so doctors can help patients stay healthier after transplant.
Hear when a new Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.